[{"id":"fc773c10-831d-4093-bf18-8c93ac9d8441","acronym":"","url":"https://clinicaltrials.gov/study/NCT00699907","created_at":"2021-01-18T02:37:00.384Z","updated_at":"2024-07-02T16:37:08.718Z","phase":"Phase 2a","brief_title":"Effect of Flutamide on Biomarkers in Blood and Tissue Samples From Patients at High Risk of Ovarian Cancer","source_id_and_acronym":"NCT00699907","lead_sponsor":"University of Arizona","biomarkers":" BRCA1 • BRCA2 • ERBB4 • CSF1R","pipe":" | ","alterations":" BRCA2 mutation • HER-2 expression • CSF1 expression • ERBB4 expression","tags":["BRCA1 • BRCA2 • ERBB4 • CSF1R"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BRCA2 mutation • HER-2 expression • CSF1 expression • ERBB4 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e flutamide"],"overall_status":"Completed","enrollment":" Enrollment 127","initiation":"Initiation: 01/01/2005","start_date":" 01/01/2005","primary_txt":" Primary completion: 11/01/2012","primary_completion_date":" 11/01/2012","study_txt":" Completion: 11/01/2014","study_completion_date":" 11/01/2014","last_update_posted":"2018-07-24"}]